AzTrials
AzTrials

Cerebral PalsyNCT06810063

Feasibility and Reliability of the Melbourne Assessment-2 (MA-2) for Telehealth

An observational study of Cerebral Palsy and Hemiplegic Cerebral Palsy, run by Ohio State University at 1 site in United States.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

The goals of this study: 1. Determine if a play based test of arm and hand movements is valid and reliable when conducted through telehealth for children with hemiplegic cerebral palsy. 2. Measure differences in parent, provider and child engagement when an assessment is conducted in-person compared to via telehealth. Read more about this study

Who is it for?
Ages 2 to 10 years
Conditions the study is for
Cerebral Palsy, Hemiplegic Cerebral Palsy
How many people
35 participants
Where
1 siteUnited States
Study dates
18 Sep 2023to May 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 2 to 10 years
  • All sexes
  • No healthy volunteers
  • Child

Study population: Children, ages 2-10 years old with hemiplegic Cerebral palsy

Who may be able to join

  • ages 2-10 years old
  • hemiplegic cerebral palsy
  • able to attend an in-person visit in the research lab OR live within 60 miles of the research lab
  • able to attend a telehealth session with personal device

Who cannot join

  • child or caregiver does not speak English
  • unable to attend one in person visit and one telehealth visit within 1 month

Trial locations and contacts

1 site in 1 country.

United States1 site
  • The Ohio State University Wexner Medical Center

    Columbus, Ohio, 43210

Other trials in United States

About this study

The goals of this study:

  1. Determine if a play based test of arm and hand movements is valid and reliable when conducted through telehealth for children with hemiplegic cerebral palsy.
  2. Measure differences in parent, provider and child engagement when an assessment is conducted in-person compared to via telehealth.
  3. Rate caregivers' overall impressions of procedures when an assessment is conducted in-person compared to telehealth.

Participants will attend two visits, one in person and one through telehealth. During each visit, the child will play with common toys. The sessions will be video recorded and scored using two standardized assessments, the Melbourne Assessment-2 (MA-2) and the Assisting Hand Assessment.

Read the detailed description

After a child has a stroke, noticeable and lifelong developmental concerns emerge. One side of the body is typically much weaker, often impacting the arm/hand more than the leg/foot, so we focus on the arm/hand. The weakness is like adults with stroke, but in children, stroke impairs play, reaching for/holding toys, communication gestures, and whole-body movement. Because of this, most children with pediatric stroke will receive physical and/or occupational therapy throughout childhood. Traditionally, rehabilitation occurs with the child, caregiver and therapist meeting in person at clinics, homes, or schools. However, telehealth rehabilitation, where the therapist and patient meet virtually through a computer or tablet, has emerged a sustainable and accessible alternative. Telehealth also has the potential to improve access to quality treatments, improve health outcomes and reduce healthcare costs. One problem with telehealth rehabilitation is that few assessments have been validated for use in telehealth. In adults with stroke, researchers have identified several assessments for that work well via telehealth. Similarly, in children with one specific brain disease, researchers found that the results of one commonly used gross motor test are similar when delivered via telehealth compared to in-person. Unfortunately, there is no studied arm/hand assessment for children with stroke. This makes it hard to measure if telehealth rehabilitation changes arm/hand function. This proposal will test two playful arm/hand assessments via telehealth. Investigators will test 35 children (2-10 years old) twice (once in-person and once via telehealth) with the same assessment and compare the results. Investigators will use two well-established assessments, the Melbourne Assessment-2 and the Assisting Hand Assessment. Both assessments will be recorded- via camera (in-person) and secure videoconferencing (telehealth). Those recordings will then be scored by a therapist trained in the Melbourne Assessment and Assisting Hand Assessment. Investigators will compare the results of both assessments to see if the scores match.

Being tested
Assessment only, no intervention
Keywords
Assessment, Telehealth
Medical subject headings
Cerebral Palsy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Assessment only, no interventionOther

    Participants in this study complete two visits to test the agreement of telehealth and in person assessments of arm and hand movement.

Study groups in NCT06810063
Study groupRoleWhat they receive
In-person vs. telehealth assessmentParticipants will be randomly assigned to in-person visit first or telehealth visit first. Both groups will complete both visits. Each visit requires about 20 minutes.
Receives: Other: Assessment only, no intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Melbourne Assessment-2

    Upper Extremity assessment, range 0-100, higher score indicates better outcomes.

    Measured: 1 month

  2. Assisting Hand Assessment

    Upper extremity assessment, range 0-100, higher score indicates better outcomes.

    Measured: 1 month

Secondary outcomes (3)
  1. Acceptability Intervention Measure

    Evaluate acceptability of telehealth assessment, 4 questions rated on 5-point Likert scale from 1 (strongly disagree) to 5 (strongly agree). Reported as proportion of items rated at or above 4/5

    Measured: immediately after telehealth visit

  2. Intervention Appropriateness Measure

    Evaluate appropriateness of telehealth assessment, 4 questions rated on 5-point Likert scale from 1 (strongly disagree) to 5 (strongly agree). Reported as proportion of items rated at or above 4/5

    Measured: immediately after telehealth visit

  3. Feasibility of Intervention Measure

    Evaluate feasibility of telehealth assessment, 4 questions rated on 5-point Likert scale from 1 (strongly disagree) to 5 (strongly agree). Reported as proportion of items rated at or above 4/5

    Measured: immediately after telehealth visit

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Feb 2025
  2. Study start18 Sep 2023
  3. Primary completion24 Nov 2025
  4. Study completionMay 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
35 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06810063
Sponsor's protocol ID
2023B0100
Status last verified
Mar 2026
First submitted
24 Jan 2025
Last updated
27 Mar 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Cerebral Palsy and Hemiplegic Cerebral Palsy, run by Ohio State University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 27 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Melbourne Assessment-2 (time frame: 1 month). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Mar 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in